Works matching Lymphocytic leukemia

Results: 5000
    1
    2
    3
    4
    5
    6
    7

    Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real‐world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 1, p. 40, doi. 10.1111/bjh.18736
    By:
    • Špaček, Martin;
    • Smolej, Lukáš;
    • Šimkovič, Martin;
    • Nekvindová, Lucie;
    • Křístková, Zlatuše;
    • Brychtová, Yvona;
    • Panovská, Anna;
    • Mašlejová, Stanislava;
    • Bezděková, Lucie;
    • Écsiová, Dominika;
    • Vodárek, Pavel;
    • Zuchnická, Jana;
    • Mihályová, Jana;
    • Urbanová, Renata;
    • Turcsányi, Peter;
    • Lysák, Daniel;
    • Novák, Jan;
    • Brejcha, Martin;
    • Líkařová, Tereza;
    • Vodička, Prokop
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).

    Published in:
    Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143376
    By:
    • Puiggros, Anna;
    • Ramos-Campoy, Silvia;
    • Kamaso, Joanna;
    • de la Rosa, Mireia;
    • Salido, Marta;
    • Melero, Carme;
    • Rodríguez-Rivera, María;
    • Bougeon, Sandrine;
    • Collado, Rosa;
    • Gimeno, Eva;
    • García-Serra, Rocío;
    • Alonso, Sara;
    • Moro-García, Marco Antonio;
    • García-Malo, María Dolores;
    • Calvo, Xavier;
    • Arenillas, Leonor;
    • Ferrer, Ana;
    • Mantere, Tuomo;
    • Hoischen, Alexander;
    • Schoumans, Jacqueline
    Publication type:
    Article
    27

    Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

    Published in:
    Cancers, 2021, v. 13, n. 13, p. 3240, doi. 10.3390/cancers13133240
    By:
    • Mauro, Francesca Romana;
    • Giannarelli, Diana;
    • Visentin, Andrea;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Frustaci, Anna Maria;
    • Chiarenza, Annalisa;
    • Ciolli, Stefania;
    • Vitale, Candida;
    • Laurenti, Luca;
    • De Paoli, Lorenzo;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Rigolin, Gian Matteo;
    • Levato, Luciano;
    • Giordano, Annamaria;
    • Del Poeta, Giovanni;
    • Stelitano, Caterina;
    • Ielo, Claudia;
    • Noto, Alessandro
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 597, doi. 10.1111/bjh.14843
    By:
    • D'Agaro, Tiziana;
    • Bittolo, Tamara;
    • Bravin, Vanessa;
    • Dal Bo, Michele;
    • Pozzo, Federico;
    • Bulian, Pietro;
    • Rossi, Francesca M.;
    • Zucchetto, Antonella;
    • Degan, Massimo;
    • D'Arena, Giovanni;
    • Chiarenza, Annalisa;
    • Zaja, Francesco;
    • Pozzato, Gabriele;
    • Di Raimondo, Francesco;
    • Rossi, Davide;
    • Gaidano, Gianluca;
    • Del Poeta, Giovanni;
    • Gattei, Valter;
    • Bomben, Riccardo
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 1, p. 56, doi. 10.1080/10428194.2019.1657575
    By:
    • Deng, Rong;
    • Gibiansky, Leonid;
    • Lu, Tong;
    • Li, Xiaobin;
    • Lu, Dan;
    • Li, Chunze;
    • Girish, Sandhya;
    • Wang, Jue;
    • Boyer, Michelle;
    • Shankar, Noopur;
    • Humphrey, Kathryn;
    • Freise, Kevin J.;
    • Salem, Ahmed Hamed;
    • Seymour, John F.;
    • Kater, Arnon P.;
    • Miles, Dale
    Publication type:
    Article
    50